NEW YORK (GenomeWeb News) – TriLink BioTechnologies today announced a $130,000 award from the National Institutes of Health to develop a sample preparation method for next-generation sequencing.
The San Diego-based firm will use its expertise in nucleic acid chemistry as part of the Phase I Small Business Innovation Research grant to develop an approach to RNA sample prep, it said. The grant last through July.
TriLink will investigate methods of reducing the formation of adapters dimers during RNA sample prep, which would eliminate the need for gel purification prior to sequencing.
"Improving the process of RNA sample preparation for next generation sequencing will increase the accessibility of this valuable tool," Richard Hogrefe, CEO of TriLink, said in a statement.